Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies
US6723319B1 · kind B1 · utility
183Cited by
1References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 14, 2000 |
| Grant date | Apr 20, 2004 |
| Priority date | — |
| Expiry date | Sep 14, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A preventive or therapeutic agent for treating bowel disease, including Crohn's disease and ulcerative colitis, where the agent has as an active ingredient an antibody directed against IL-6 receptor which is an interleukin-6 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.